NR1H4 and Insulin resistance: There were also no significant differences in whole-body glucose clearance rates or suppression of endogenous glucose production between the groups, indicating that FXR activation did not prevent or aggravate initial development of glucose intolerance and insulin resistance (Figure 4h,i).